Two is better than one. At least that may prove to be the case with hybrid approaches that combine PET’s ability to assess myocardial blood flow with other modalities for diagnosing coronary artery disease.

A number of factors are standing out as promoters for and protectors against the development of Alzheimer’s disease, according to research presented during the 2014 Alzheimer’s Association International Conference (AAIC) that was held July 12-17 at the Bella Center in Copenhagen, Denmark.

One is a long-established option for colorectal cancer screening, the other is still fighting for Medicare coverage but has proven to be effective in clinical studies. Over the last week, the Huffington Post has hosted four experts providing their take on whether patients should seek out colonoscopy or CT colonography.

Researchers found increases in image noise equivalent to a 50 percent reduction in patient radiation dose on low-contrast liver CT scans can be achieved without substantially affecting sensitivity, according to a study published in the October issue of Academic Radiology.

The challenge was delivered with stark clarity. “We need to establish a new approach to make it easy and affordable for our faculty to quickly transition their imaging probe research from cells and what they see in animal models into human subjects.

As the 2014 Annual Meeting for the Society of Nuclear Medicine and Molecular Imaging (SNMMI) came to a close this year in St. Louis, Molecular Imaging Insight sat down with Barry A. Siegel, MD, professor of radiology and medicine and chief of the nuclear medicine division at local Washington University School of Medicine. 

There are a number of perennial destinations for the molecular imaging set that deliver cutting-edge research and promote clinical discussion, but, for many clinicians and researchers, the Society of Nuclear Medicine and Molecular Imaging’s Annual Meeting is the one conference they attend all year.

Advanced low-grade non-Hodgkin lymphoma (NHL) typically leads to relapse and death in patients who undergo conventional chemo and radiation therapies, but the emergence of radioimmunotherapy (RIT) in recent years has provided an encouraging alternative.